PERSISTENCE OF RILMENIDINE THERAPY COMPARE TO ANGIOTENSIN CONVERTING INHIBITORS AND ANGIOTENSIN II RECEPTOR BLOCKERS IN HYPERTENSION. THE PEAK STUDY